2025-2033年按病毒类型（基因工程溶瘤病毒、溶瘤野生型病毒）、应用（实体瘤、黑色素瘤）、最终用途（医院、专科诊所、癌症研究所）及地区分類的溶瘤病毒疗法市场报告

2024年全球溶瘤病毒疗法市场规模达1.908IMARC Group美元。

溶瘤病毒疗法是一种利用病毒感染和破坏癌细胞的免疫疗法。他们使用各种天然和基因改造病毒，如单纯疱疹病毒、新城疫病毒、痘苗病毒、腺病毒、呼肠孤病毒和小核糖核酸病毒。溶瘤病毒疗法会活化危险讯号以产生免疫反应，并广泛用于治疗实体瘤、黑色素瘤和不可切除的病灶。它们还使用仅感染和破坏目标肿瘤细胞的病毒来帮助根除肿瘤。与化疗相比，溶瘤病毒疗法无毒，疗效优越，可延长癌症患者的存活期。因此，它们在医院、诊所和癌症研究机构中得到了广泛的应用。

溶瘤病毒疗法市场趋势：

全球癌症发生率的上升为市场创造了积极的前景。溶瘤病毒疗法因其强大的抗肿瘤特性以及在不伤害周围组织的情况下准确靶向肿瘤的能力而被广泛用于治疗各种癌症，例如胶质母细胞瘤、乳腺癌、肺癌和前列腺癌。与此一致的是，该疗法广泛用于治疗各种类型的黑色素瘤，如血液恶性肿瘤、淋巴瘤、白血病和骨髓瘤，有利于市场成长。此外，患者对手术介入、放射治疗、化疗和免疫疗法等各种癌症治疗对健康的负面影响日益担忧，这极大地推动了市场成长。此外，越来越多的溶瘤病毒（例如疱疹病毒、腺病毒和牛痘病毒）临床研究数量不断增加，这些研究已处于最后阶段，并已证明了良好的实验结果，正在促进市场成长。其他因素，包括对先进治疗和新疗法的需求不断增长，以及多个政府为提高对不同癌症原因的认识并促进早期诊断而采取的更多倡议，预计将推动市场成长。

本报告回答的关键问题

• 2024年全球溶瘤病毒疗法市场规模有多大？ 2025-2033年全球溶瘤病毒疗法市场的预期成长率是多少？
• 推动全球溶瘤病毒疗法市场的关键因素是什么？
• COVID-19 对全球溶瘤病毒疗法市场有何影响？
• 全球溶瘤病毒治疗市场的关键地区有哪些？
• 谁是全球溶瘤病毒疗法市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

• 研究目的
• 利害关係人
• 数据来源
  • 主要来源
  • 二手资料
• 市场预测
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第 3 章：执行摘要

第 4 章：简介

• 概述
• 主要行业趋势

第 5 章：全球溶瘤病毒治疗市场

• 市场概况
• 市场表现
• COVID-19 的影响
• 市场预测

第 6 章：市场区隔：依病毒类型

• 基因工程溶瘤病毒
  • 市场趋势
  • 关键环节
    • 单纯疱疹病毒
    • 腺病毒
    • 痘苗病毒
  • 市场预测
• 溶瘤野生型病毒
  • 市场趋势
  • 关键环节
    • 呼肠孤病毒
    • 新城疫病毒
    • 水泡性口炎病毒
  • 市场预测

第 7 章：市场区隔：按应用

• 实体肿瘤
  • 市场趋势
  • 关键环节
    • 乳癌
    • 摄护腺癌
    • 肺癌
    • 胶质母细胞瘤
  • 市场预测
• 黑色素瘤
  • 市场趋势
  • 关键环节
    • 血液系统恶性肿瘤
    • 淋巴瘤
    • 白血病
    • 骨髓瘤
  • 市场预测

第 8 章：市场区隔：最终用途别

• 医院
  • 市场趋势
  • 市场预测
• 专科诊所
  • 市场趋势
  • 市场预测
• 癌症研究所
  • 市场趋势
  • 市场预测

第 9 章：市场区隔：按地区

• 北美洲
  • 美国
  • 加拿大
• 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
• 中东和非洲
  • 市场趋势
  • 市场细分：按国家/地区
  • 市场预测

第 10 章：SWOT 分析

• 概述
• 优势
• 弱点
• 机会
• 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

• 概述
• 买家的议价能力
• 供应商的议价能力
• 竞争程度
• 新进入者的威胁
• 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

• 市场结构
• 关键参与者
• 关键参与者简介
  • Amgen Inc.
  • Dnatrix Inc.
  • Genelux Corporation
  • Lokon Pharma AB
  • Replimune Group Inc.
  • Rigvir Ltd.
  • Sorrento Therapeutics
  • Takara Bio Inc. (Takara Holdings Inc.)
  • Targovax
  • TILT Biotherapeutics Ltd
  • Transgene SA
  • Vyriad

The global oncolytic virus therapies market size reached USD 190.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 797.9 Million by 2033, exhibiting a growth rate (CAGR) of 16.37% during 2025-2033.

Oncolytic virus therapies are a form of immunotherapy that utilizes viruses to infect and destroy cancer cells. They use various natural and genetically modified viruses, such as herpes simplex, Newcastle disease, vaccinia, adenovirus, reovirus, and picornavirus. Oncolytic virus therapies activate danger signals for generating an immune response and are widely used for treating solid tumors, melanoma, and unresectable lesions. They also help eradicate tumors using viruses that only infect and destroy targeted tumor cells. As compared to chemotherapy, oncolytic virus therapies are non-toxic, provide superior efficacy, and prolong the survival of cancer patients. As a result, they find extensive applications in hospitals, clinics, and cancer research institutes.

Oncolytic Virus Therapies Market Trends:

The rising incidences of cancer across the globe are creating a positive outlook for the market. Oncolytic virus therapies are widely used to treat various cancers, such as glioblastoma, breast, lung, and prostate cancers, due to their powerful anti-tumor properties and ability to target tumors accurately without harming surrounding tissues. In line with this, the widespread utilization of the therapy to treat various types of melanomas, such as hematological malignancies, lymphoma, leukemia, and myeloma, is favoring the market growth. Furthermore, rising concerns among patients regarding the negative health impact of various cancer treatments, such as surgical intervention, radiotherapy, chemotherapy, and immunotherapy, are providing a considerable boost to the market growth. Additionally, the rising number of clinical studies in oncolytic viruses, such as herpesvirus, adenovirus, and vaccinia virus, that is in the final stages and have demonstrated excellent experimental results are facilitating the market growth. Other factors, including rising demand for advanced treatments and novel therapies and increasing initiatives by several governments to spread awareness regarding different causes of cancer and promote early diagnosis, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Virus Type:

Genetically Engineered Oncolytic Viruses

Herpes Simplex Virus

Adenovirus

Vaccinia Virus

Oncolytic Wild-Type Viruses

Reovirus

Newcastle Disease Virus

Vesicular Stomatitis Virus

Breakup by Application:

Solid Tumors

Breast Cancer

Prostate Cancer

Lung Cancer

Glioblastoma

Melanoma

Hematological Malignancies

Lymphoma

Leukemia

Myeloma

Breakup by End Use:

Hospitals

Specialty Clinics

Cancer Research Institute

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Dnatrix Inc., Genelux Corporation, Lokon Pharma AB, Replimune Group Inc., Rigvir Ltd., Sorrento Therapeutics, Takara Bio Inc. (Takara Holdings Inc.), Targovax, TILT Biotherapeutics Ltd, Transgene SA and Vyriad. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. What was the size of the global oncolytic virus therapies market in 2024?
• 2. What is the expected growth rate of the global oncolytic virus therapies market during 2025-2033?
• 3. What are the key factors driving the global oncolytic virus therapies market?
• 4. What has been the impact of COVID-19 on the global oncolytic virus therapies market?
• 5. What are the key regions in the global oncolytic virus therapies market?
• 6. Who are the key players/companies in the global oncolytic virus therapies market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Oncolytic Virus Therapies Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Virus Type

• 6.1 Genetically Engineered Oncolytic Viruses
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Herpes Simplex Virus
    • 6.1.2.2 Adenovirus
    • 6.1.2.3 Vaccinia Virus
  • 6.1.3 Market Forecast
• 6.2 Oncolytic Wild-Type Viruses
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Reovirus
    • 6.2.2.2 Newcastle Disease Virus
    • 6.2.2.3 Vesicular Stomatitis Virus
  • 6.2.3 Market Forecast

7 Market Breakup by Application

• 7.1 Solid Tumors
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Breast Cancer
    • 7.1.2.2 Prostate Cancer
    • 7.1.2.3 Lung Cancer
    • 7.1.2.4 Glioblastoma
  • 7.1.3 Market Forecast
• 7.2 Melanoma
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Hematological Malignancies
    • 7.2.2.2 Lymphoma
    • 7.2.2.3 Leukemia
    • 7.2.2.4 Myeloma
  • 7.2.3 Market Forecast

8 Market Breakup by End Use

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Specialty Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cancer Research Institute
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Amgen Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Dnatrix Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Genelux Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Lokon Pharma AB
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Replimune Group Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Rigvir Ltd.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Sorrento Therapeutics
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 Takara Bio Inc. (Takara Holdings Inc.)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Targovax
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 TILT Biotherapeutics Ltd
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Transgene SA
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
  • 14.3.12 Vyriad
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

• Figure 1: Global: Oncolytic Virus Therapies Market: Major Drivers and Challenges
• Figure 2: Global: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Oncolytic Virus Therapies Market: Breakup by Virus Type (in %), 2024
• Figure 5: Global: Oncolytic Virus Therapies Market: Breakup by Application (in %), 2024
• Figure 6: Global: Oncolytic Virus Therapies Market: Breakup by End Use (in %), 2024
• Figure 7: Global: Oncolytic Virus Therapies Market: Breakup by Region (in %), 2024
• Figure 8: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Oncolytic Virus Therapies (Solid Tumors) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Oncolytic Virus Therapies (Solid Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Oncolytic Virus Therapies (Melanoma) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Oncolytic Virus Therapies (Melanoma) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Oncolytic Virus Therapies (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Oncolytic Virus Therapies (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Oncolytic Virus Therapies (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Oncolytic Virus Therapies (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: North America: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: North America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: United States: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: United States: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Canada: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Canada: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Asia-Pacific: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Asia-Pacific: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: China: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: China: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Japan: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Japan: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: India: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: India: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: South Korea: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: South Korea: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Australia: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Australia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: Indonesia: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: Indonesia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Others: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Europe: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Europe: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Germany: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Germany: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: France: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: France: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: United Kingdom: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: United Kingdom: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Italy: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Italy: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Spain: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Spain: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Russia: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Russia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Others: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Latin America: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Latin America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Brazil: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Brazil: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Mexico: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Mexico: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Others: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Middle East and Africa: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Middle East and Africa: Oncolytic Virus Therapies Market: Breakup by Country (in %), 2024
• Figure 70: Middle East and Africa: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Global: Oncolytic Virus Therapies Industry: SWOT Analysis
• Figure 72: Global: Oncolytic Virus Therapies Industry: Value Chain Analysis
• Figure 73: Global: Oncolytic Virus Therapies Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Oncolytic Virus Therapies Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Virus Type (in Million USD), 2025-2033
• Table 3: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Oncolytic Virus Therapies Market Forecast: Breakup by End Use (in Million USD), 2025-2033
• Table 5: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Oncolytic Virus Therapies Market: Competitive Structure
• Table 7: Global: Oncolytic Virus Therapies Market: Key Players